UK markets closed

Bionano Genomics, Inc. (0A4K.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
2.1880-0.2520 (-10.33%)
At close: 06:57PM GMT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.75
52-week change 3N/A
S&P500 52-week change 316.69%
52-week high 32.2250
52-week low 32.1150
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8282.89M
% held by insiders 12.17%
% held by institutions 125.66%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-369.80%

Management effectiveness

Return on assets (ttm)-18.06%
Return on equity (ttm)-34.37%

Income statement

Revenue (ttm)15.67M
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)112.00%
Gross profit (ttm)2.77M
EBITDA -55.88M
Net income avi to common (ttm)-61.22M
Diluted EPS (ttm)-0.2500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)326.07M
Total cash per share (mrq)1.13
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)19.32
Book value per share (mrq)1.21

Cash flow statement

Operating cash flow (ttm)-58.41M
Levered free cash flow (ttm)-28.41M